Results 1 to 10 of about 105,569 (120)

Clinical Effects of Vitamin D on the Control of Bronchial Asthma-Is it Relevant? [PDF]

Journal of Clinical and Diagnostic Research, 2020
Bronchial asthma is one of the most common chronic respiratory disease worldwide, and is characterised by different phenotypic variations. Acute exacerbations in bronchial asthma are common and leads to repeated hospitalisations leading to increase in ...
Gajanan S Gaude, Sreenija Kummarganti, Jyothi Hattiholi   +2 more
doaj   +1 more source

Practical Recommendations for a Selection of Inhaled Corticosteroids in COPD: A Composite ICO Chart

Biomolecules, 2023
The use of inhaled corticosteroids (ICS) for the maintenance of bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD) is controversial.
Keiji Oishi, Kazuto Matsunaga, Tasuku Yamamoto, Kazuki Matsuda, Yoriyuki Murata, Tsunahiko Hirano   +5 more
doaj   +1 more source

LONG-TERM AZITHROMYCIN TREATMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE [PDF]

Journal of IMAB, 2020
Purpose: To assess the efficacy of Azithromycin on exacerbations in patients with chronic obstructive pulmonary disease (COPD) and history of two or more flare-ups in the last 12 months and to study the influence of concomitant bronchiectasis on its ...
Vanya Kostadinova, Yordan Radkov, Temenuga Stoeva, Darina Miteva   +3 more
doaj   +1 more source

Serum uric acid levels and uric acid/creatinine ratios: affordable biomarkers for predicting chronic obstructive pulmonary disease severity and exacerbations

Egyptian Journal of Chest Disease and Tuberculosis, 2018
Background Chronic obstructive pulmonary disease (COPD) is an essential initiate the conditions of mortality and morbidity. Objective This study evaluated the clinical importance of measuring the level of serum uric acid (sUA) level and uric acid ...
Hesham A AbdelHalim, Heba H AboElNaga
doaj   +1 more source

A Cross-Sectional Study on Prescription Patterns of Short-Acting β2-Agonists in Patients with Asthma: Results from the SABINA III Colombia Cohort

Journal of Asthma and Allergy, 2022
John Carlos Pedrozo-Pupo,1 Manuel Conrado Pacheco Gallego,2 Iván de Jesús Baños Álvarez,3 Rodolfo Antonio Jaller Raad,4 Andrea Carolina Caballero Pinilla,5 Humberto Reynales Londoño,6 Laura Bernal Villada,7 Maarten Beekman8 1PREVICARE LTDA.
Pedrozo-Pupo JC, Pacheco Gallego MC, Baños Álvarez IDJ, Jaller Raad RA, Caballero Pinilla AC, Reynales Londoño H, Bernal Villada L, Beekman M   +7 more
doaj  

Asthma-related hospitalizations after implementing SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen

European Clinical Respiratory Journal, 2022
Overreliance on short-acting β2-agonists (SABA) has been a common feature of asthma management globally for at least 30 years. However, given the evidence against the long-term use of SABA, including potentially increased risk of exacerbations, emergency
L. J. Nannini, N. S. Neumayer, N. Brandan, O. M. Fernández, D. M. Flores   +4 more
doaj   +1 more source

The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study

International Journal of COPD, 2021
Kjell Larsson,1 Christer Janson,2 Karin Lisspers,3 Björn Ställberg,3 Gunnar Johansson,3 Florian S Gutzwiller,4 Karen Mezzi,4 Bine Kjoeller Bjerregaard,5 Leif Jorgensen5 1Integrative Toxicology, The National Institute of Environmental Medicine ...
Larsson K, Janson C, Lisspers K, Ställberg B, Johansson G, Gutzwiller FS, Mezzi K, Bjerregaard BK, Jorgensen L   +8 more
doaj  

Anemia Severely Reduces Health-Related Quality of Life in COPD Patients Receiving Long-Term Home Non-Invasive Ventilation

International Journal of COPD, 2021
Maximilian Wollsching-Strobel, Sarah Bettina Schwarz, Tim Mathes, Daniel Sebastian Majorski, Pouya Heidari, Doreen Kroppen, Friederike Sophie Magnet, Wolfram Windisch Cologne Merheim Hospital, Department of Pneumology, Kliniken der Stadt Köln gGmbH ...
Wollsching-Strobel M, Schwarz SB, Mathes T, Majorski DS, Heidari P, Kroppen D, Magnet FS, Windisch W   +7 more
doaj  

Plasma Extracellular Vesicle miRNA Profiles Distinguish Chronic Obstructive Pulmonary Disease Exacerbations and Disease Severity

International Journal of COPD, 2022
Hannah E O’Farrell, Rayleen V Bowman, Kwun M Fong, Ian A Yang Faculty of Medicine, the University of Queensland, Brisbane, QLD, AustraliaCorrespondence: Hannah E O’Farrell, Faculty of Medicine, the University of Queensland, Brisbane, QLD, Australia, Tel +
O'Farrell HE, Bowman RV, Fong KM, Yang IA   +3 more
doaj  

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

Respiratory Research, 2011
Background NVA237 is a once-daily dry-powder formulation of the long-acting muscarinic antagonist glycopyrronium bromide in development for the treatment of chronic obstructive pulmonary disease (COPD). The glycopyrronium bromide in COPD airways clinical
D'Urzo Anthony, Ferguson Gary T, van Noord Jan A, Hirata Kazuto, Martin Carmen, Horton Rachael, Lu Yimeng, Banerji Donald, Overend Tim   +8 more
doaj   +1 more source